Ticker
SPRYCompany Name
ARS PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Gross Profit | Gross Margin | Revenues |
---|---|---|---|
6/30/2025 | $ 105.28M | 93.72% | $ 112.34M |
3/31/2025 | $ 95.05M | 97.87% | $ 97.12M |
12/31/2024 | $ 88.17M | 98.9% | $ 89.15M |
9/30/2024 | $ 2.46M | 95.64% | $ 2.57M |
6/30/2024 | $ 500K | 100% | $ 500K |
3/31/2024 | $ 10K | 100% | $ 10K |
12/31/2023 | $ 30K | 100% | $ 30K |
9/30/2023 | $ 1.35M | 100% | $ 1.35M |
6/30/2023 | $ 1.35M | 100% | $ 1.35M |
3/31/2023 | $ 1.34M | 100% | $ 1.34M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
GP / Revenues
(=) Gross %
Gross % for ARS PHARMACEUTICALS INC is calculated as follows: GP [ $ 0 ] / Revenues [ $ 0 ]
(=) Gross % [ 0% ]
Minimum
Jun 30, 2025
Maximum
Dec 31, 2022
Average
Median
filtered constituents | 3.81K |
---|---|
min | -72.25% |
max | 150.26% |
average | 53.09% |
median | 49.46% |
std | 31.59% |